Clinical Trial Update: Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating elimination of CD4+CD25+ regulatory T cells in patients with advanced hepatocellular carcinoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Hannover Medical School | Conditions: Advanced HCC | Phase 3 | Status: COMPLETED